27 results
8-K12B
EX-10.1
BNTC
Benitec Biopharma Inc
15 Apr 20
Notification of registration of securities
9:04am
to, arising out of or resulting from such Indemnifiable Claim. In connection with any such payment, advancement or reimbursement, if delivery … of an undertaking is a legally required condition precedent to such payment, advance or reimbursement or is otherwise requested by the Company, Indemnitee shall
10-K
2020 FY
BNTC
Benitec Biopharma Inc
23 Sep 20
Annual report
4:50pm
and delivery, price, the level of competition and the availability of reimbursement from government and other third- party-payers.
Our commercial … proceed.
The requirements and process governing the conduct of clinical trials, product approval or licensing, pricing and reimbursement vary from country
S-1
faznhtc7
14 Aug 20
IPO registration
4:11pm
S-1
EX-10.3
01tozx0hcqn5pre8ljrv
14 Aug 20
IPO registration
4:11pm
8-K
EX-4.3
hx1r7qs9kkt1un ob
11 Aug 23
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
4:01pm
8-K
EX-4.3
pxk2j6y6s
16 Sep 22
Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering
8:58am
S-3
EX-4.2
fi9hiizi
18 Feb 21
Shelf registration
4:03pm
8-K12B
EX-3.2
9g4b qpsetdbmmh29273
15 Apr 20
Notification of registration of securities
9:04am
8-K
EX-1.1
86933 6qf8t02zb6ayxd
29 Apr 21
Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock
5:05pm